Neurology C ase P resentation August 31 st , 2012
description
Transcript of Neurology C ase P resentation August 31 st , 2012
![Page 1: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/1.jpg)
Neurology Case Presentation
August 31st, 2012Dipika AggarwalPGY 4 Neurology
![Page 2: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/2.jpg)
2
Teen aged male admitted with acute onset generalized weakness for 1 day duration
Woke up with diffuse weakness; no anti gravity strength in arms, unable to get out of bed
Proximal > distal weakness; bilaterally symmetrical Denied diplopia, dysphagia, dysarthria, facial droop,
drooling or change in level of consciousness
![Page 3: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/3.jpg)
3
Denied any sensory complains Denied trouble breathing, urinary or bowel
incontinence Denied any recent illness, trauma, travel or tick bite One episode of non-bloody emesis prior to
admission
![Page 4: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/4.jpg)
4
PMH: similar episode four months earlier, admitted to OSH for 4-5 days, ?? Diagnosed with GBS, ?? treated with plasmapheresis, no LP/ EMG
PSH: none Home meds: None FH: HTN, migraine, DM, asthma, no similar problem
in family members SH: denies smoking, ETOH or illicit drug use
![Page 5: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/5.jpg)
5
Vitals stable General physical exam unremarkable Neurological exam
◦Mental status: AAO * 4◦Speech : fluent with comprehension intact◦CN 2-12: PERRLA, EOMI, normal facial sensation
and symmetry, normal facial strength, hearing intact, equal palatal elevation and tongue midline
Physical exam
![Page 6: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/6.jpg)
6
◦Motor: Flaccid tone, motor strength 2/5 proximally and 3-4/5 distally BUE and BLE
◦DTRs: Areflexic , toes downgoing◦Sensory: Intact to LT/PP/ Vibration and
proprioception ◦Unable to test for cerebellar function and gait
![Page 7: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/7.jpg)
7
Where??
What??
![Page 8: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/8.jpg)
8
Hb - 14.6, WBC 6.1, Plt count 215 Sodium 143, K 1.3, Chloride 110, BUN 13, Creatinine
0.83, Glucose 151, Calcium 9.3, Magnesium 2.0, Phosphorus 2.4
CK 493, Aldolase 15.7 (on day 3) TSH: 2.082, free T3 – 3.8, free T4 – 0.9 Urine lytes: unremarkable
Labs
![Page 9: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/9.jpg)
9
Aggressive Potassium replacement Started showing improvement in muscle strength on
day 1 By day 2 – strength was 5/5 BUE and BLE Diagnosed with familial hypokalemic periodic
paralysis Discharged with follow up care with Jayhawk clinic
Hospital course
![Page 10: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/10.jpg)
10
Non dystrophic myotonias ◦Myotonia congenita (CLCN1)◦Paramyotonia congenita (SCN4A)◦Sodium channel myotonias (potassium aggravated
myotonias) (SCN4A) Periodic paralyses
◦Hypokalemic (CACNA1S/ SCN4A)◦Hyperkalemic (SCN4A)◦Anderson Tawil syndrome (KCNJ2)
Muscle channelopathies
![Page 11: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/11.jpg)
11
Hypokalemic:◦Thyrotoxic periodic paralysis◦hyperaldosteronism◦RTA◦villous adenoma◦cocaine binge◦diuretics, licorice, steroids, ETOH
Hyperkalemic (k>7): ◦hyporenemic hypoaldosteronism (DM/CRF)◦oral K, CRF, chronic heparin, rhabdomyolysis
Normakalemic: ◦Guanidine, sleep paralysis, MG, TIA, conversion
Periodic Paralysis Secondary
![Page 12: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/12.jpg)
12
HypoKPP1 and 2 - CACNA1S/ SCN4A gene HypoKPP 1 is the most frequent form 1 in 100,000 Autosomal dominant inheritance pattern M:F – 3 or 4:1 Onset: first 2 decades of life
Hypokalemic periodic paralysis
![Page 13: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/13.jpg)
13
Flaccid paralysis – mild focal weakness to severe generalized weakness
Occur anytime of the day; more common in morning Absence of myotonia Proximal > distal weakness; legs > arms Sparing of facial, ventilatory and sphincter muscles Lasts several hours to more than a day
Clinical features
![Page 14: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/14.jpg)
14
Frequency: highly variable Frequency decreases after age 30; may become
attack free in 40s and 50s Permanent fixed weakness or slowly progressive
weakness more common with HypoKPP1 Attacks may be preceded by sensation of heaviness
and or aching in the low back
![Page 15: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/15.jpg)
15
Strenuous physical activity followed by rest or sleep High carb diet ETOH consumption Emotional stress Concurrent viral illness Lack of sleep Medications like beta agonists, corticosteroids, and
insulin
Precipitating factors
![Page 16: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/16.jpg)
16
Mutations in voltage sensor segment D2S4 of 1 subunit of skeletal muscle Ca channel gene, chromosome 1q
Arg528His, Arg1239His, Arg1239Gly Less commonly SCN4A mutation enhances Na
inactivation
Hypokalemic Periodic ParalysisGenetics
![Page 17: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/17.jpg)
17
The mutation slows the activation rate of L-type Ca current to 30% of NL
Reduced RYR1-mediated Ca release from SER Reduced calcium current density Impaired E-C coupling ? role of K and ? inexcitability Ca homeostasis change reduces ATP-dependent K
channel current and leads to abnormal depolarization (Tricarico D et al 1999)
Hypokalemic Periodic ParalysisPathophysiology
![Page 18: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/18.jpg)
18
Serum K < 3.0mEq/L Serum CK level elevated EKG changes – U waves, flattening of T waves Provocative testing - Intravenous glucose load/
insulin Electrophysiology
◦ Sensory and motor NCS normal between attacks◦ During attacks – small CMAP. Reduced insertional activity,
fibs and positive sharp waves◦ No myotonia on EMG◦ Short/ long exercise test
Diagnostic studies
![Page 19: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/19.jpg)
19
Muscle biopsy reserved to atypical patients with normal provocative and gene testing
Vacuoles reflect permanent myopathy Vacuoles represent proliferation, degeneration and
autophagic destruction of T-tubules & SR Large central vacuoles in hypokalemic PP
Periodic ParalysisMuscle Pathology
![Page 20: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/20.jpg)
20
Hypokalemic Periodic Paralysis
![Page 21: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/21.jpg)
21
Reducing exposure to known triggers Acute treatment – replacement of K Acetazolamide – prevent attack recurrence and
severity ◦Acetazolamide may ppt weakness in HypoKPP2
Dichlorphenamide – no longer available Triamterene and spironolactone
Treatment
![Page 22: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/22.jpg)
22
R/O secondary forms Measure K+ during attack Provocative testing for PP: seldom done!
o Hypo: gluc/insulino Hyper: K+
Muscle Bx – vacuoles/dilated T-tubules Electrophysiology
o EMGo Short/long exercise tests
Genetics
Diagnosing Muscle Channelopathies
![Page 23: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/23.jpg)
23
More useful in MC Baseline CMAP Exercise 10 sec Record CMAP immediately post
exercise, then q 10 sec for 1 min. CMAP in MC and PMC PMC exacerbated by cold No change in CMAP in HypoKPP
Electrophysiology: Short Exercise Test
(Streib. Musc. Nerve. 1982; 5: 719-723)
(Fournier. Ann. Neurol. 2004; 56: 650-661) (Fournier Neurology 2009)
![Page 24: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/24.jpg)
24
Record ulnar CMAP Amp baseline Exercise ADM 5 min Check CMAP every 2 min. for 50
min In PP (all types), Amp immed post
ex, over next 10-40 min, grad dec amp
In MC ↓ Amp immed post ex, rapid return to baseline
In PMC sustained ↓ Amp
Long Exercise Test for Periodic Paralysis
(McManis. Musc. Nerve. 1986; 9: 704-710)
(Fournier. Ann. Neurol. 2004; 56: 650-661)
![Page 25: Neurology C ase P resentation August 31 st , 2012](https://reader036.fdocuments.in/reader036/viewer/2022062520/56816449550346895dd60ffa/html5/thumbnails/25.jpg)
25
Dr.Barohn’s presentation on “Muscle Channelopathies” Anthony A.Amato and James A.Russell; Non dystrophic myotonias and
periodic paralysis. Neuromuscular disorders 2008, Mc Graw Hill, Section II Chapter 29; 655-680
Burge JA, Hanna MG. Novel insights into the pathomechanisms of skeletal muscle channelopathies; Curr Neurol Neurosci Rep. 2012 Feb Vol 12:62-69
Hanna, Dipa L Raja Rayan and Michael G. Skeletal Muscle Channelopathies:Non Dystrophic Myotonias and Periodic Paralysis. Current Opinion in Neurology, 2010 Vol. 23: 466-476
neuromuscular.wustl.edu Doreen Fialho and Michael G.Hanna. Periodic paralysis, Handbook of
Clinical Neurology, 2007 Vol. 86 (3rd series), p 89-90
References